Shanghai Allist Pharmaceuticals Co Ltd Sustainability Reports
Shanghai Allist Pharmaceuticals Co., Ltd. is a biopharmaceutical enterprise that integrates R&D, manufacturing, and commercialization of innovative small-molecule oncology medications. The company focuses primarily on developing novel therapies for non-small cell lung cancer.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG007J38S98
2 reports from 2024 to 2025